Trial Details

RECRUITING
Basic Information
Clinical ID c1144
Identifier NCT05509777
Trial Title A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Crohn's Disease
Interventions DRUG: Mirikizumab
Participant Information
Sponsor Eli Lilly and Company
City Los Angeles
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement CHILD
Study Design
Study Type INTERVENTIONAL
Phase PHASE3
Time Information
Start Date 2024-03-13
Primary Completion Date 2027-12
Completion Date 2028-04